How Jingling Took a Easy Thought and Raised $10 Million

The worldwide reputation of pill computer systems is on the rise, and it’s not arduous to see why: they’re light-weight, they connect with the web almost anyplace, and so they make glorious transportable leisure programs. 

So, if tablets are so helpful, why do customers solely have a alternative between iOS and Android working programs?

Jingling is on a mission to vary the pill panorama by providing a 3rd possibility — a consumer-grade Linux pill — that makes no compromises. Jingling lately launched their first Linux pill on Indiegogo, the Jingpad A1, which raised almost $150,000 in a matter of minutes, proving the deep marketplace for Linux-based tablets. Their idea has gained a lot traction, the truth is, that the group lately secured $10 million in seed funding from outstanding Enterprise Capital agency Sinovation.

The origin of the Jingpad A1

The story of JingPad begins three years in the past when Jingling’s CEO observed there was a spot within the consumer-level Linux pill market. When he posted his commentary on Reddit, he obtained 73 feedback in a single day, which piqued his curiosity. 

After doing a little deeper market evaluation throughout the Linux neighborhood, he found that no consumer-grade Linux tablets existed available on the market, so he noticed a possibility. The Jingling JingPad was born.

The world’s first consumer-oriented, open-source pill

The Jingpad A1 is the world’s first consumer-level Linux pill, constructed across the idea of open-source working programs and software program. It brings all one of the best points of iOS and Android tablets — a big show, top-tier computing energy, glossy design — and provides a further layer of customizability. As a Linux-based pill, it’s absolutely open supply, so customers can tinker with almost any a part of the working system.

And Jingling’s hunch round market demand has confirmed appropriate. When JingPad launched on Indiegogo earlier this 12 months, it raised slightly below $150,000 in simply 15 minutes, validating the marketplace for a consumer-grade Linux pill. 

“That was such an thrilling evening for all of us,” says Yumeng Cheng, Head of Branding at Jingling. “We didn’t know what to anticipate once we launched, and it was such an unimaginable shock once we raised the $150,000 so rapidly. Fifteen minutes!” 

“We realized that our neighborhood of backers had been so passionate for a Linux pill, and we had been providing one thing that didn’t exist earlier than,” Cheng continues. “It’s been a whirlwind.”

Jingling secures $10 million in enterprise capital 

And the whirlwind doesn’t cease there. In June, it was introduced that Sinovation Ventures, a outstanding enterprise capital agency based mostly in Beijing, could be funding Jingling’s $10 million seed spherical. “We’re thrilled to get this form of validation from such an enormous participant within the area. $10 million definitely will give us a terrific head begin,” Cheng says.

The way forward for JingPad is brilliant

With $10 million within the financial institution, the Jingling group is worked up to take their operation to the subsequent stage.

“Our technique is to make use of our seed funding to spend money on world-class R&D,” Cheng explains. “We all know that design and growth are on the core of each distinctive product, so we plan on specializing in constructing out our product roadmap.” 

She provides:

“Our imaginative and prescient is to supply a 3rd viable possibility within the pill panorama past iOS and Android. I feel we simply bought a bit of bit nearer to creating that imaginative and prescient a actuality.”

To study extra concerning the Jingling JingPad A1, try their marketing campaign web page right here.